Known Interactions Between Acyclovir and Other Antivirals
Acyclovir, used for herpes infections, has minimal direct interactions with most other antivirals due to its renal excretion and specific mechanism (viral DNA polymerase inhibition). No major pharmacokinetic clashes occur with drugs like oseltamivir (for flu) or HIV antiretrovirals (e.g., tenofovir, emtricitabine). However, overlapping toxicities can arise, particularly nephrotoxicity when combined with drugs like ganciclovir or foscarnet, both of which stress the kidneys.[1][2]
Risks with CMV or Herpes Zoster Antivirals
Combining acyclovir with ganciclovir (for cytomegalovirus) increases nephrotoxicity risk, as both rely on renal clearance and can cause crystal-induced kidney damage. Case reports show elevated creatinine levels, sometimes requiring dose adjustments or hydration. Valganciclovir, ganciclovir's prodrug, follows the same pattern. Foscarnet adds risks of electrolyte imbalances and further renal impairment.[3][4]
Interactions in HIV or Hepatitis Treatment
In HIV regimens, acyclovir pairs safely with most nucleoside reverse transcriptase inhibitors (NRTIs) like zidovudine or lamivudine, but monitor for additive CNS effects (dizziness, confusion) with high-dose zidovudine. With protease inhibitors (e.g., ritonavir), no significant issues, though ritonavir may slightly raise acyclovir levels via CYP inhibition. For hepatitis, combinations with entecavir or tenofovir show no notable antiviral synergies or conflicts, but shared renal pathways warrant monitoring in patients with low GFR.[2][5]
What Happens with Overlapping Use in the Same Patient
Patients on multiple antivirals for coinfections (e.g., herpes + CMV in immunocompromised individuals) face heightened risks of acute kidney injury, especially if dehydrated or elderly. Symptoms include reduced urine output, fatigue, and rising BUN/creatinine. Guidelines recommend spacing doses, aggressive hydration, and periodic renal function tests.[1][6]
Monitoring and Prevention Strategies
Check baseline kidney function before starting combos. Adjust acyclovir dosing (e.g., prolong intervals) if CrCl <50 mL/min. No routine drug level monitoring exists for acyclovir, but watch for rare hypersensitivity cross-reactions with valacyclovir or famciclovir. Probenecid can boost acyclovir exposure by blocking secretion, amplifying side effects in poly-antiviral therapy.[4][7]
When to Avoid or Seek Alternatives
Avoid combos in patients with prior renal issues unless benefits outweigh risks, opting for topical acyclovir or alternatives like penciclovir. Consult infectious disease specialists for complex cases like transplant recipients.[3][5]
[1]: FDA Acyclovir Label
[2]: Lexicomp: Acyclovir Interactions
[3]: UpToDate: Acyclovir Drug Interactions
[4]: Medscape: Acyclovir Dosing and Interactions
[5]: NIH HIV Guidelines: Opportunistic Infections
[6]: Drugs.com Interaction Checker
[7]: Micromedex: Acyclovir